Prostaglandin E‐induced polycyclic cutaneous eruption with geometric features
Pediatric Dermatology · 2024
DOI: 10.1111/pde.15617 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von Ananya Shah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Rochester, Rochester, New York, USA. Hauptthemen laut MEDLINE: Alprostadil. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Prostaglandin E1 (PGE1) is a substance produced by the patent ductus arteriosus that keeps it open. PGE1 can be a lifesaving drug for infants born with ductus‐dependent congenital heart disease (CHD) where there is a block of blood flow to the lungs or transposition of great arteries. We present a case of a 36‐week, 2‐day gestation neonate with CHD who developed bright erythematous annular and polycyclic patches on day 2 of PGE1 administration. When PGE1 dosing was decreased, the rash resolved on its own. Our case demonstrates that PGE1 treatment may not need to be interrupted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Rochester, Rochester, New York, USA.
ORCID-Profile: Ananya Shah
Zitieren
APA
Shah, A., El-Feghaly, J., & Bender, A. M. (2024). Prostaglandin E‐induced polycyclic cutaneous eruption with geometric features. Pediatric Dermatology. https://doi.org/10.1111/pde.15617
Vancouver
Shah A, El-Feghaly J, Bender AM. Prostaglandin E‐induced polycyclic cutaneous eruption with geometric features. Pediatric Dermatology. 2024. doi:10.1111/pde.15617
BibTeX
@article{Shah2024,
author = {Shah, Ananya and El-Feghaly, Jinia and Bender, Alexandra M},
title = {Prostaglandin E‐induced polycyclic cutaneous eruption with geometric features},
journal = {Pediatric Dermatology},
year = {2024},
doi = {10.1111/pde.15617}
}
EUVIMED